Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans.

Nature genetics | Oct 27, 2007

http://www.ncbi.nlm.nih.gov/pubmed/17828264

More than a billion humans worldwide are predicted to be completely deficient in the fast skeletal muscle fiber protein alpha-actinin-3 owing to homozygosity for a premature stop codon polymorphism, R577X, in the ACTN3 gene. The R577X polymorphism is associated with elite athlete status and human muscle performance, suggesting that alpha-actinin-3 deficiency influences the function of fast muscle fibers. Here we show that loss of alpha-actinin-3 expression in a knockout mouse model results in a shift in muscle metabolism toward the more efficient aerobic pathway and an increase in intrinsic endurance performance. In addition, we demonstrate that the genomic region surrounding the 577X null allele shows low levels of genetic variation and recombination in individuals of European and East Asian descent, consistent with strong, recent positive selection. We propose that the 577X allele has been positively selected in some human populations owing to its effect on skeletal muscle metabolism.

Pubmed ID: 17828264 RIS Download

Mesh terms: Actinin | Alleles | Animals | Asian Continental Ancestry Group | European Continental Ancestry Group | Genetic Variation | Humans | Immunohistochemistry | Mice | Mice, Knockout | Models, Animal | Models, Genetic | Muscle, Skeletal | Physical Endurance | Polymorphism, Genetic | Selection, Genetic

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.